Clinical Trial Update: Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating interleukin-2 versus observation after standard therapy in adults with recurrent non-Hodgkin lymphoma has completed. The study includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Lymphoma
• Diffuse Large B-cell Lymphoma
• Follicular Lymphoma
• Immunoblastic Large Cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Interleukin-2 (interleukin-2)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma | Phase 3 | Status: COMPLETED